Kuros Biosciences is a pioneering brand that is dedicated to providing targeted and controlled solutions for bone healing. Their mission is to eliminate non-unions and improve patient rehabilitation. With over 150 years of combined research experience in the field of biologics for spinal fusion, Kuros Biosciences offers innovative products and services that are designed to revolutionize the future of spinal fusions.

Their flagship product, MagnetOs, is a unique bone graft that has the remarkable ability to grow bone even in soft tissue, thanks to its NeedleGrip™ surface technology. This groundbreaking product ensures more efficient and predictable fusions. Additionally, Kuros Biosciences is proud to introduce their latest innovation, Fibrin-PTH, which is the first-ever investigational drug-biologic candidate to be evaluated for spinal fusion.

It has the potential to be a true game changer in the field. Supported by a team of world-renowned spinal surgeons and experts, Kuros Biosciences is committed to advancing the science and clinical evidence behind bone grafts through their global research program, Project Fusion. Their goal is to provide surgeons, medical organizations, and insurers with a greater quantity and quality of scientific knowledge to make informed decisions about bone graft selection.

Discover more about Kuros Biosciences and their groundbreaking research by visiting their website or reaching out to them directly. Their passion for innovation and commitment to improving patient outcomes make them a trusted leader in the field of biologics for spinal fusion